Summaries of safety labeling changes approved by FDA—boxed warnings highlights, October–December 2021.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 525, doi. 10.1093/ajhp/zxac048
- Publication type:
- Article
Works matching IS 10792082 AND DT 2022 AND VI 79 AND IP 7
Results: 18
1
2
News briefs.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 526, doi. 10.1093/ajhp/zxac050
- Publication type:
- Article
3
Summaries of safety labeling changes approved by FDA—boxed warnings highlights October–December 2021.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. e93, doi. 10.1093/ajhp/zxac049
- Publication type:
- Article
4
Pandemic strains student pharmacists.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 524, doi. 10.1093/ajhp/zxac047
- By:
- Publication type:
- Article
5
Tezepelumab-ekko.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 521, doi. 10.1093/ajhp/zxab491
- Publication type:
- Article
6
Efgartigimod Alfa-fcab.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 519, doi. 10.1093/ajhp/zxab490
- Publication type:
- Article
7
Pralsetinib: Treatment of metastatic RET fusion–positive non–small cell lung cancer.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 527, doi. 10.1093/ajhp/zxab462
- By:
- Publication type:
- Article
8
relationship of vancomycin 24-hour AUC and trough concentration.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 534, doi. 10.1093/ajhp/zxab457
- By:
- Publication type:
- Article
9
Personality: A potentially untapped resource in the selection of postgraduate pharmacy residents.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 540, doi. 10.1093/ajhp/zxab450
- By:
- Publication type:
- Article
10
Looking two steps ahead.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 556, doi. 10.1093/ajhp/zxab446
- By:
- Publication type:
- Article
11
Evaluation of high-dose insulin/euglycemia therapy for suspected β-blocker or calcium channel blocker overdose following guideline implementation.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 547, doi. 10.1093/ajhp/zxab439
- By:
- Publication type:
- Article
12
ASHP Standard for Certification as a Center of Excellence in Medication-Use Safety and Pharmacy Practice.
- Published in:
- American Journal of Health-System Pharmacy, 2022, v. 79, n. 7, p. 564, doi. 10.1093/ajhp/zxab368
- Publication type:
- Article
13
Corrigendum to: Actions of the ASHP Board of Directors – Meetings of January 28-29 and February 18, 2021.
- Published in:
- 2022
- Publication type:
- Correction Notice
14
Corrigendum to: Budgeting in the post-COVID era: Be in the room where it happens.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
15
Erratum to: Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
16
Erratum to: Strategies used to meet the challenges of mass COVID-19 vaccination by the pharmacy department in a large academic medical center.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
17
Correction Notice.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
18
Correction Notice.
- Published in:
- 2022
- Publication type:
- Correction Notice